BMO Capital Maintains Outperform on Nutrien, Lowers Price Target to $75
Portfolio Pulse from Benzinga Newsdesk
BMO Capital analyst Joel Jackson maintains an Outperform rating on Nutrien (NYSE:NTR) but lowers the price target from $80 to $75.

August 09, 2024 | 4:03 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
BMO Capital analyst Joel Jackson maintains an Outperform rating on Nutrien but lowers the price target from $80 to $75.
The Outperform rating suggests a positive outlook, but the lowered price target indicates some caution. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100